Since its 2021 launch, Novo Nordisk’s Wegovy set the stage for the next generation of anti-obesity drugs that target the gut’s weight-regulating mechanisms. Now, a new drug on the scene promises to be more effective and safer than any other weight loss drug before.
Subscribe to:
Post Comments (Atom)
< + > Optimum Healthcare IT Frees Health Care Providers to Focus on Strategy
There is a lot of talk about staffing shortages and cost pressures in the health care industry. But Scott Gildea, Executive Vice President, ...
No comments:
Post a Comment